MEDNAX (MD) Tops Q4 EPS by 8c; Issues 2022 EBITDA Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
Mednax Reports Fourth Quarter Results
February 17, 2022 6:00 AM ESTFORT LAUDERDALE, Fla.--(BUSINESS WIRE)-- Mednax, Inc. (NYSE: MD), and its affiliated practices operating as Pediatrix® Medical Group, the nations leading provider of highly specialized health care for women, children and babies, today reported earnings from continuing operations of $0.47 per share for the three months ended December 31, 2021. On a non-GAAP basis, Mednax reported Adjusted EPS from continuing operations of $0.52.
For the 2021 fourth quarter, Mednax reported the following results from continuing operations:
Net revenue of $499 million; Income from continuing operations of $68 million;... More